First humans take experimental drug in safety check
NCT ID NCT06780254
Summary
This was the first study in humans to test the safety and tolerability of a new drug called MH-001. It involved 58 healthy volunteers who received either the drug or a placebo. The main goal was to see what side effects might occur and to measure how the drug moves through and stays in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Syneos Health clinic
Québec, Quebec, G1P 0A2, Canada
Conditions
Explore the condition pages connected to this study.